Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2015 | The Nordic Lymphoma Group (NLG) study in adult anaplastic large cell lymphoma

Francesco d'Amore • 4 Dec 2015
ASH 2015
T-Cell Lymphoma Etoposide

Francesco d’Amore, MD, PhD from Aarhus University, Aarhus, Denmark talks about the Nordic Lymphoma Group (NLG) study on the addition of etoposide to CHOP in adult anaplastic large cell lymphoma patients. Dr d’Amore discusses how the addition of etoposide improves the outcome of patients, as demonstrated by the Phase II clinical trial published in 2012 on the use of CHOEP bi-weekly followed by autologous transplant consolidation in young patients.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting in Orlando, FL.

More from Francesco d'Amore

7:22
Managing T-cell lymphomas in light of the updated WHO classification
Francesco d'Amore • 27 Sep 2019
16:57
Clinical trials, pathologies and developments in personalized medicine
Francesco d'Amore et al. • 18 Sep 2017
iwNHL 2017: T-cell lymphomas, Hodgkin's lymphoma, immunotherapy and epigenetics
Francesco d'Amore et al. • 8 Sep 2017
6:49
Update of peripheral T-cell lymphoma treatment
Elaine Jaffe et al. • 5 Sep 2014

Related Videos

1:13
Antibody-drug conjugates for the treatment of lymphoma
Pau Abrisqueta • 5 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
3:17
PET imaging to predict treatment outcomes: follow-up from the ECHELON-2 trial
Swaminathan Iyer • 11 Dec 2023
2:39
The significance of CD30 in the response to brentuximab vedotin for patients with T-cell lymphoma
Swaminathan Iyer • 11 Dec 2023
The content of VJHemOnc is intended for healthcare professionals